PRO 2000

DB05385InvestigationalSmall molecule

PRO 2000 is an investigational medicine that is not yet approved by the FDA for use outside of clinical trials. It is being studied for the prevention of HIV infection... This medicine does not cure HIV infection or AIDS and is being studied to reduce the risk of passing the virus to other people.

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in HIV prevention, prevention of stdis, and vaginal infection.Curator reviewed
Also known as
Polynaphthalene sulphonate
Code names
Pro 1041 · PRO-2000 · PRO 2000/5

Resolves to

What you can answer from here — as of July 03, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PRO 2000, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account